Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Plaxe

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|December 31, 1997
Endometrioid ovarian carcinoma in a premenarchal girl: report of a caseD Fink, S C Plaxe, J F Brown, et al.
Investigational New Drugs|April 9, 2001
A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group StudyS C Plaxe, J A Blessing, J A Lucci, et al.
Obstetrics and Gynecology|February 1, 1990
Clinical features and treatment outcome of patients with epithelial carcinoma of the ovary metastatic to the central nervous systemS C Plaxe, P R Dottino, R Lipsztein, et al.
Gynecologic Oncology|January 1, 1991
Induction chemotherapy followed by radical surgery in cervical cancerP R Dottino, S C Plaxe, A M Beddoe, et al.
JAMA|February 19, 1982
Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomachH W Bruckner, P T Lavin, S C Plaxe, et al.
The New England Journal of Medicine|May 29, 1986
In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalisP A Grannum, J A Copel, S C Plaxe, et al.
Gynecologic Oncology|May 1, 1990
Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapyS C Plaxe, P R Dottino, H M Goodman, et al.
Obstetrics and Gynecology|May 1, 1993
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancerS C Plaxe, P S Braly, J L Freddo, et al.
Journal of the National Cancer Institute|May 1, 1991
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamoleS Isonishi, S Kirmani, S Kim, et al.
Cancer|July 15, 1994
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignanciesE F McClay, P D Braly, S Kirmani, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|December 31, 1997
Endometrioid ovarian carcinoma in a premenarchal girl: report of a caseD Fink, S C Plaxe, J F Brown, et al.
Investigational New Drugs|April 9, 2001
A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group StudyS C Plaxe, J A Blessing, J A Lucci, et al.
Obstetrics and Gynecology|February 1, 1990
Clinical features and treatment outcome of patients with epithelial carcinoma of the ovary metastatic to the central nervous systemS C Plaxe, P R Dottino, R Lipsztein, et al.
Gynecologic Oncology|January 1, 1991
Induction chemotherapy followed by radical surgery in cervical cancerP R Dottino, S C Plaxe, A M Beddoe, et al.
JAMA|February 19, 1982
Absolute granulocyte, lymphocyte, and moncyte counts. Useful determinants of prognosis for patients with metastatic cancer of the stomachH W Bruckner, P T Lavin, S C Plaxe, et al.
The New England Journal of Medicine|May 29, 1986
In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalisP A Grannum, J A Copel, S C Plaxe, et al.
Gynecologic Oncology|May 1, 1990
Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapyS C Plaxe, P R Dottino, H M Goodman, et al.
Obstetrics and Gynecology|May 1, 1993
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancerS C Plaxe, P S Braly, J L Freddo, et al.
Journal of the National Cancer Institute|May 1, 1991
Phase I and pharmacokinetic trial of intraperitoneal etoposide in combination with the multidrug-resistance-modulating agent dipyridamoleS Isonishi, S Kirmani, S Kim, et al.
Cancer|July 15, 1994
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignanciesE F McClay, P D Braly, S Kirmani, et al.
Pageof 3